Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Declares $0.09 Monthly Dividend

Key Points

• The Neuberger Berman High Yield Strategies Fund declared a monthly dividend of $0.09 per share, set to be paid on October 31st, for stockholders of record on October 15th.
• The dividend represents a 14.5% annualized yield based on the current share price.
• As of the latest trading session, the fund's stock is down 0.3%, with a current trading price of $7.48 and a one-year trading range between $6.62 and $8.57.

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) announced a monthly dividend on Tuesday, September 30th. Stockholders of record on Wednesday, October 15th will be paid a dividend of 0.0905 per share by the investment management company on Friday, October 31st. This represents a c) dividend on an annualized basis and a dividend yield of 14.5%. The ex-dividend date of this dividend is Wednesday, October 15th.

Neuberger Berman High Yield Strategies Fund Stock Down 0.3%

Neuberger Berman High Yield Strategies Fund stock traded down $0.03 during trading hours on Wednesday, hitting $7.48. The company had a trading volume of 25,616 shares, compared to its average volume of 177,314. Neuberger Berman High Yield Strategies Fund has a one year low of $6.62 and a one year high of $8.57. The firm has a 50-day moving average of $7.49 and a 200 day moving average of $7.50.

Neuberger Berman High Yield Strategies Fund Company Profile

Neuberger Berman High Yield Strategies Fund Inc is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.